The brugada syndrome

被引：33
作者：
Brugada P. [1 ]
Brugada R. [2 ]
Brugada J. [3 ]
机构：
[1] Cardiovascular Center, OLV Hospital, 9300 Aalst
[2] Baylor College of Medicine, Houston, TX
[3] Arrhythmia Unit, Hospital Clinic, University of Barcelona
来源：
Current Cardiology Reports | 2000年 / 2卷 / 6期
关键词：
Sudden Death; Sudden Cardiac Death; Antiarrhythmic Drug; Flecainide; Brugada Syndrome;
D O I：
10.1007/s11886-000-0035-0
中图分类号：
学科分类号：
摘要：
The Brugada syndrome is a hereditary disease causing sudden cardiac death in apparently healthy individuals with a structurally normal heart. The disease is caused by mutations in the cardiac sodium channel gene SCN5A. Patients with this disease have a peculiar electrocardiogram with elevation of the ST segment in leads V1 to V3, an electrocardiogram that every doctor should recognize. There exist variants of the electrocardiogram with minimal ST segment elevation and even concealed forms that can only be unmasked by the administration of class I antiarrhythmic drugs. When left untreated or when treated with all known antiarrhythmic drugs, patients with Brugada syndrome have a high mortality (approximately 10% per year). The only effective treatment to prevent sudden death is the implantable defibrillator. Copyright © 2000 by Current Science Inc.
引用
收藏
页码：507 / 514
页数：7
相关论文
共 83 条
[1]  
Brugada P., Brugada J., Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome, J Am Coll Cardiol, 20, pp. 1391-1396, (1992)
[2]  
Bjerregaard P., Gussak I., Kotar S.L., Et al., Recurrent syncope in a patient with prominent J wave, Am Heart J, 127, pp. 1426-1430, (1994)
[3]  
Brugada P., Geelen P., Some electrocardiographic patterns predicting sudden cardiac death that every doctor should recognize, Acta Cardiol, 52, pp. 473-484, (1997)
[4]  
Bjerregaard P., Gussak I., Antzelevitch C., The enigmatic manifestation of Brugada syndrome, J Cardiovasc Electrophysiol, 9, pp. 109-110, (1998)
[5]  
Matduo K., Shimizu W., Kurita T., Et al., Dynamic changes of 12-lead electrocardiograms in a patient with Brugada syndrome, J Cardiovasc Electrophysiol, 9, pp. 508-512, (1998)
[6]  
Prieto-Solis J.A., Martin-Duran A., Multiples cambios en la morfologia del segmento ST en un paciente con sindrome de Brugada, Rev Esp Cardiol, 53, pp. 136-138, (2000)
[7]  
Brugada P., Brugada syndrome: An electrocardiographic diagnosis not to be missed, Heart, 84, pp. 1-3, (2000)
[8]  
Miyazaki T., Mitamura H., Miyoshi S., Et al., Autonomic and antiarrhythmic modulation of ST segment elevation in patients with Brugada syndrome, J Am Coll Cardiol, 27, pp. 1061-1070, (1996)
[9]  
Nakazato Y., Shimada K., Nakazato K., Et al., Abnormal ST elevation during oral pilsicainide treatment, Ther Res, 18, pp. 357-362, (1997)
[10]  
Nakazato Y., Nakata Y., Yasuda M., Et al., Safety and efficacy of oral flecainide acetate in patients with cardiac arrhythmias, Jpn Heart J, 38, pp. 379-385, (1997)
123456789